Avrobio is using ‘pods’ to create gene therapies, and it believes the approach could change the game altogether

Geoff MacKay

Where other companies have gone big, Avrobio is going small. Its manufacturing operation is no different.

Instead of trying to keep up with the validation of new facilities — and spending money and precious time in the process — the company has opted...

Click to view original post